Skip to main content
SpringerLink
Log in
Book cover

Cellular Pathology of Glandular Lesions and Uncommon Neoplasms of the Cervix pp 53–70Cite as

Premalignant Glandular Lesions of the Cervix

  • Chapter
  • First Online:

Abstract

Premalignant endocervical glandular lesions are increasing in incidence. The various terminologies applied to these lesions (adenocarcinoma in situ or cervical glandular intraepithelial neoplasia), which are the precursors of usual type cervical adenocarcinoma, are discussed. These lesions are usually associated with high risk human papillomavirus (HPV) infection. The morphological features are discussed, as is the immunophenotype, differential diagnosis and management.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Friedell GA, McKay DG. Adenocarcinoma in situ of the endocervix. Cancer. 1953;6:887–97.

    Article  PubMed  CAS  Google Scholar 

  2. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490–3.

    Article  PubMed  CAS  Google Scholar 

  3. Hemminki K, Li X, Vaittinen P. Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958–1996. Eur J Obstet Gynecol Reprod Biol. 2002;101:64–9.

    Article  PubMed  Google Scholar 

  4. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States- a 24 year population-based study. Gynecol Oncol. 2000;78:97–105.

    Article  PubMed  CAS  Google Scholar 

  5. Fox H, Buckley CH. Histopathology reporting in cervical screening. NHSCSP Publication, No 10; 1999.

    Google Scholar 

  6. Tavassoli FA, Devilee P, editors. World Health Organisation Classification of Tumours. Pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press; 2003.

    Google Scholar 

  7. Brown LJ, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion. J Clin Pathol. 1986;39:22–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. McCluggage WG. Endocervical glandular lesions: controversial aspects and ancillary techniques. J Clin Pathol. 2003;56:164–73.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  9. Gloor E, Hurlmann J. Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). Cancer. 1986;58:1272–80.

    Article  PubMed  CAS  Google Scholar 

  10. Houghton O, Jamison J, Wilson R, Carson J, McCluggage WG. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection. Histopathology. 2010;57:342–50.

    Article  PubMed  Google Scholar 

  11. Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol. 2011;35:633–46.

    Article  PubMed  Google Scholar 

  12. Leary J, Jaworski R, Houghton R. In-situ hybridization using biotinylated DNA probes to human papillomavirus in adenocarcinoma-in-situ and endocervical glandular dysplasia of the uterine cervix. Pathology. 1991;23:85–9.

    Article  PubMed  CAS  Google Scholar 

  13. Tase T, Okagaki T, Clark BA, et al. Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. Int J Gynecol Pathol. 1989;8:8–17.

    Article  PubMed  CAS  Google Scholar 

  14. Thomas DB, Ray RM. Oral contraceptive and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Am J Epidemiol. 1996;144:281–9.

    Article  PubMed  CAS  Google Scholar 

  15. Jones MW, Silverberg SG. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol. 1989;73:984–9.

    Article  PubMed  CAS  Google Scholar 

  16. Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31:664–72.

    Article  PubMed  Google Scholar 

  17. Nara M, Hashi A, Murata S, et al. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol. 2007;106:289–98.

    Article  PubMed  Google Scholar 

  18. Kondo T, Hashi A, Murata S, et al. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod Pathol. 2005;18:1199–210.

    Article  PubMed  CAS  Google Scholar 

  19. Goldstein NS, Ahmad E, Hussain M, Hankin RC, Perez-Reyes N. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol. 1998;110:200–9.

    PubMed  CAS  Google Scholar 

  20. Ioffe OB, Sagae S, Moritani S, Dahmoush L, Chen TT, Silverberg SG. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions “less than” adenocarcinoma in situ? Point Int J Gynecol Pathol. 2002;22:18–21.

    Article  Google Scholar 

  21. Lee KR. Symposium part 3: Should pathologists diagnose endocervical preneoplastic lesions “less than” adenocarcinoma in situ? Counterpoint. Int J Gynecol Pathol. 2002;22:22–4.

    Article  Google Scholar 

  22. Kurian K, Al-Nafussi A. Relation of cervical glandular intraepithelial neoplasia to microinvasive and invasive adenocarcinoma of the uterine cervix: a study of 121 cases. J Clin Pathol. 1999;52:112–7.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  23. Lee KR, Sun D, Crum CP. Endocervical intraepithelial glandular atypia (dysplasia): A histopathologic, human papillomavirus, and MIB1 analysis of 25 cases. Hum Pathol. 2000;31:656–64.

    Article  PubMed  CAS  Google Scholar 

  24. Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Chapter 5. Precursors of cervical adenocarcinoma. In: Blaustein’s pathology of the female genital tract. 6th ed. Springer; New York: 2011, p. 225–8.

    Google Scholar 

  25. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol. 2000;79:207–10.

    Article  PubMed  CAS  Google Scholar 

  26. Jaworski RC, Pacey NF, Greenberg ML, et al. The histologic diagnosis of adenocarcinoma in situ and related lesions of the cervix uteri. Cancer. 1988;61:1171–81.

    Article  PubMed  CAS  Google Scholar 

  27. Chang MC, Nevadunsky NS, Viswanathan AN, Crum CP, Feltmate CM. Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long term survival. Int J Gynecol Pathol. 2010;29:88–92.

    Article  PubMed  Google Scholar 

  28. Yemelyanova A, Vang R, Seidman JD, Gravitt PE, Ronnett BM. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol. 2009;33:914–24.

    Article  PubMed  Google Scholar 

  29. Al-Fehmi R, Qureshi F, Lawrence WG, Jacques SM. Apoptosis, proliferation, and expression of p53 and bcl-2 in endocervical glandular intraepithelial lesions and invasive endocervical adenocarcinoma. Int J Gynecol Pathol. 2004;23:1–6.

    Article  Google Scholar 

  30. Moritani S, Ioffe OB, Sagae S, Dahmoush L, Silverberg SG, Hattori T. Mitotic activity and apotosis in endocervical glandular lesions. Int J Gynecol Pathol. 2002;21:125–33.

    Article  PubMed  Google Scholar 

  31. Biscotti CV, Hart WR. Apoptotic bodies. A consistent morphological feature of endocervical adenocarcinoma in situ. Am J Surg Pathol. 1998;22:434–9.

    Article  PubMed  CAS  Google Scholar 

  32. Witkiewicz A, Lee KR, Brodsky G, Cviko A, Brodsky J, Crum CP. Superficial (early) endocervical adenocarcinoma in situ: a study of twelve cases and comparison to conventional AIS. Am J Surg Pathol. 2005;29:1609–14.

    Article  PubMed  Google Scholar 

  33. Ioffe OB, Sagae S, Moritani S, Dahmoush L, Chen TT, Silverberg SG. Proposal of a new scoring scheme for the diagnosis of noninvasive endocervical glandular lesions. Am J Surg Pathol. 2003;27:452–60.

    Article  PubMed  Google Scholar 

  34. McCluggage WG, Shah R, Connolly LE, McBride HA. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol. 2008;27:92–100.

    Article  PubMed  CAS  Google Scholar 

  35. Nicolae A, Goyenaga P, McCluggage WG, Preda O, Nogales FF. Endometrial intestinal metaplasia: a report of two cases, including one associated with cervical intestinal and pyloric metaplasia. Int J Gynecol Pathol. 2011;30:492–6.

    Article  PubMed  Google Scholar 

  36. Mikami Y, McCluggage WG. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol. 2013;20:227–37.

    Article  PubMed  CAS  Google Scholar 

  37. Howitt BE, Herfs M, Brister K, Oliva E, Longtine J, Hecht JL, Nucci MR. Intestinal-type endocervical adenocarcinoma in situ. An immunophenotypically distinct subset of AIS affecting older women. Am J Surg Pathol. 2013;37:625–33.

    Article  PubMed  Google Scholar 

  38. Schlesinger C, Silverberg SG. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia. Int J Gynecol Pathol. 1999;73:305–11.

    CAS  Google Scholar 

  39. McCluggage WG. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology. 2007;39:97–111.

    Article  PubMed  CAS  Google Scholar 

  40. Cameron RI, Maxwell P, Jenkins D, McCluggage WG. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology. 2002;41:313–21.

    Article  PubMed  CAS  Google Scholar 

  41. Negri G, Bellisano G, Carico E, et al. Usefulness of p16ink4a, ProEXC, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri. Int J Gynecol Pathol. 2011;30:407–13.

    Article  PubMed  Google Scholar 

  42. O’Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol. 2006;13:8–15.

    Article  PubMed  Google Scholar 

  43. Sanati S, Huettner P, Yiagan LR. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens. Int J Gynecol Pathol. 2010;29:79–87.

    Article  PubMed  Google Scholar 

  44. Marques T, Andrade LA, Vassallo J. Endocervical tubal metaplasia and adenocarcinoma in situ: role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis. Histopathology. 1996;28:549–50.

    Article  PubMed  CAS  Google Scholar 

  45. Stewart CJ, Little L. Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium. Pathology. 2010;42:217–33.

    Article  PubMed  CAS  Google Scholar 

  46. Little L, Stewart CJ. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions. Mod Pathol. 2010;23:611–8.

    Article  PubMed  CAS  Google Scholar 

  47. Li C, Rock KL, Woda BA, Jiang Z, Fraire AE, Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16 (INK4a) expression. Mod Pathol. 2007;20:241–7.

    Google Scholar 

  48. McCluggage WG, Soslow RA, Gilks CB. Patterns of p53 immunoreactivity in endometrial carcinomas: 'all or nothing' staining is of importance. Histopathology. 2011;59:786–8.

    Article  PubMed  Google Scholar 

  49. McCluggage WG, Hurrell DP, Kennedy K. Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. Am J Surg Pathol. 2010;34:735–41.

    PubMed  Google Scholar 

  50. Goldstein NS, Mani A. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol. 1998;109:727–32.

    PubMed  CAS  Google Scholar 

  51. Salani R, Puri I, Bristow RE. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conisation margin status. Am J Obstet Gynecol. 2009;200:182e1–5.

    Article  Google Scholar 

  52. Krivak TC, Retherford B, Voskuil S, Rose GS, Alagoz T. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ. Gynecol Oncol. 2000;77:334–5.

    Article  PubMed  CAS  Google Scholar 

  53. Hurrell DP, Jamison J, Dobbs SP, McCluggage WG. Cervical adenocarcinoma in situ recurring as vaginal adenocarcinoma 16 years after hysterectomy. Int J Gynecol Pathol. 2009;28:296–300.

    Article  PubMed  Google Scholar 

  54. Park JJ, Sun D, Quade BJ, et al. Stratified mucin producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol. 2000;24:1414–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Royal Victoria Hospital, Belfast, UK

    W. Glenn McCluggage

Authors
  1. W. Glenn McCluggage
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

McCluggage, W.G. (2014). Premalignant Glandular Lesions of the Cervix. In: Cellular Pathology of Glandular Lesions and Uncommon Neoplasms of the Cervix. Springer, London. https://doi.org/10.1007/978-1-4471-2210-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2210-4_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2209-8

  • Online ISBN: 978-1-4471-2210-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation